ArticleEye (London, England)2013
Patterns of adherence behaviour for patients with glaucoma.
Article in Eye (London, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 35 citations in OpenAlex.
- African Americans' Hemodialysis Treatment Adherence Data Assessment and Presentation: A Precision-Based Paradigm Shift to Support Quality Improvement Activities.Kidney medicine · 2022Article
- Whitecoat Adherence in Patients With Primary Open-Angle Glaucoma.Frontiers in medicine · 2022Article
- Predicting Adherence With the Glaucoma Treatment Compliance Assessment Tool.Journal of glaucoma · 2020Article
- Comparing Combination Drop Therapy to a Standard Drop Regimen After Routine Cataract Surgery.Clinical ophthalmology (Auckland, N.Z.) · 2020Article
- Observational
- Patient-Reported Nonadherence with Glaucoma Therapy.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2019Article
- Investigation of medication adherence and reasons for poor adherence in patients on long-term glaucoma treatment regimes.Patient preference and adherence · 2019Review
- Relationship between electronically measured medication adherence and vision-related quality of life in a cohort of patients with open-angle glaucoma.BMJ open ophthalmology · 2018Article
- Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices: An Updated Review.PharmacoEconomics · 2018Review
- Adherence to Glaucoma Medications Over 12 Months in Two US Community Pharmacy Chains.Journal of clinical medicine · 2016Article
- Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia.BMC ophthalmology · 2016Article
- Medical Management of Glaucoma in the 21st Century from a Canadian Perspective.Journal of ophthalmology · 2016Review
- Patterns of Glaucoma Medication Adherence over Four Years of Follow-Up.Ophthalmology · 2015Article
- Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors.Clinical therapeutics · 2015Observational
- Pharmacotherapy and Adherence Issues in Treating Elderly Patients with Glaucoma.Drugs & aging · 2015Review
- Patient satisfaction with glaucoma therapy: reality or myth?Clinical ophthalmology (Auckland, N.Z.) · 2015Article
- Modeling Patterns of Medication Adherence in Primary Open-Angle Glaucoma.Ophthalmology scienceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
Abstract
aims and purposeAdherence to long-term treatment regimens for primary open-angle glaucoma holds a challenge for both clinicians and patients. The study aims were to (i) establish the magnitude of travoprost non-adherence using an Electronic Adherence Monitor (EAM), (ii) compare electronic with patient self-reported adherence, and (iii) explore the application of a previously reported method of graphically presenting adherence data to a larger cohort over a longer monitoring period.
methodsA cohort study of patients using travoprost for glaucoma or ocular hypertension was conducted. All participants used an EAM and adherence data were collected prospectively for 2 months. Self-reported adherence was obtained using the Morisky Medication Adherence Scale (MMAS); patients also reported frequency of missed doses. Potential predictors of adherence were collected via a structured interview. EAM-recorded interdose intervals were plotted graphically.
resultsOf 100 patients invited to participate, 98 consented and EAM data were collected successfully from 88 participants. The median EAM adherence score for the cohort was 88.9% (interquartile range: 71.2, 92.2). When dichotomised (≥80%: adherent; <80%: non-adherent), EAM identified 36.7% as non-adherent and MMAS 12.2%. EAM data were used to classify five types of adherence behaviour including a category representing levels of ≥97% maintained by 21% of participants.
conclusionEAM revealed good adherence to glaucoma monotherapy but poor agreement with patient self-reported adherence. An adherence category of persistent and exceptionally high adherence to travoprost over a 2-month period was identified.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.